Advanced lung cancer: A clinical trial of radiotherapy plus two drug combination regimens.
D000230:Adenocarcinoma / Q000628:therapy; D000577:Amides / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002277:Carcinoma / Q000401:mortality / Q000628:therapy*; D018288:Carcinoma, Small Cell / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D003037:Cobalt Radioisotopes; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000401:mortality / Q000628:therapy*; D008466:Mechlorethamine / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D011867:Radioisotope Teletherapy; D012075:Remission, Spontaneous; D014226:Triazenes / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000577:Amides; D000970:Antineoplastic Agents; D003037:Cobalt Radioisotopes; D007093:Imidazoles; D009607:Nitrosourea Compounds; D014226:Triazenes; D008466:Mechlorethamine; D014750:Vincristine; D005472:Fluorouracil; D006918:Hydroxyurea